Should we be concerned are we in trouble ?

Discussion in 'Antares Pharma' started by anonymous, Jul 13, 2019 at 8:01 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Are layoffs coming?
     

  2. anonymous

    anonymous Guest


    Why would there be layoffs? The company is growing at a record pace!
    They just leased a 75,000 sf location for a combo production site, lab and warehouse due to the surging demands on business growth.
     
  3. anonymous

    anonymous Guest

    We shall see on Tuesday AM during the 2nd quarter conference call.
     
  4. anonymous

    anonymous Guest

    Very good conference call. This company is surging with products, sales and revenue stream. It is worth listening to the call.
     
  5. anonymous

    anonymous Guest

    surging with products are you kidding? what products are you talking about
    also not achieving numbers for current portfolio
     
  6. anonymous

    anonymous Guest

    Another smoke and mirrors assessment by Antares! Not surprising. There management is slimy, at best. Also, they just let go of a bunch of sales reps...hmmm, maybe to boost bottom line? Antares management, GET A CLUE. Quit hiding the exploding syringes...I wonder if anyone has gotten hurt?
     
  7. anonymous

    anonymous Guest

    How many sales reps were let go and which locations?

    Any color on "exploding syringes" that you can share?
     
  8. anonymous

    anonymous Guest

    The products are not all promoted by Antares but other partners. This is the situation.
     
  9. anonymous

    anonymous Guest

    The exploding syringes are the result of the medicine breaking down the plastic of the device compromising the plastic and leaving it weakened. This leaves the contracted spring within the device like a 70lb-force loaded weapon.

    there were at least 5 sales reps let go.
     
  10. anonymous

    anonymous Guest

    Thanks, Professor
     
  11. anonymous

    anonymous Guest

    The exploding syringes are the result of the medicine breaking down the plastic of the device compromising the plastic and leaving it weakened. This leaves the contracted spring within the device like a 70lb-force loaded weapon.

    there were at least 5 sales reps let go.
     
  12. anonymous

    anonymous Guest

    This makes no sense. If the medicine breaks down the plastic as you say, what will the medicine do to the patient? Especially since these medicines are not novel but drugs used very longterm historically, just the delivery injector. If Makena, Epineferine and testosterone which are drugs that the injectors carry this has never been experienced before with other competitor injectors. Plastic is plastic!

    This sounds like sour grapes as you also post 5 reps were let go. Maybe you are one of them?
     
  13. anonymous

    anonymous Guest

    Not a sales rep! Also, I didn’t state epi did this. The excipients of the drugs for testosterone and Makena break down plastic. This is the result of poor quality by design. Yes, it is possible to have an injectable breakdown plastic and not harm the patient. Perhaps you should do your homework or maybe you too are just another Antares pharma sheep that doesn’t care about safety or quality by design?
     
  14. anonymous

    anonymous Guest

    Looks like Makena will be off the market soon per the FDA request. I wonder how they will make that up? Perhaps their partnership to make Narcan syringe for Pfizer? Or maybe Epi? Or maybe having everyone work 12 hour days will help! Bahahaha! Sounds like an awesome place to work. Lol!
     
  15. anonymous

    anonymous Guest

    This company is a joke! They can’t even keep up with demand for Epi. They won’t be making Makena anymore. The CEO is a doofus. The board and execs are fumbling to figure out what to do next now that Xyosted is approved. I’ve got an answer....drain the swamp!
     
  16. anonymous

    anonymous Guest

    Do you work here